ARVINAS, INC. Uncategorized Contracts & Agreements
12 Contracts & Agreements
- Amended and Restated (Filed With SEC on February 23, 2023)
- Master In Vitro Diagnostics Agreement (Filed With SEC on August 4, 2022)
- Investor Agreement, dated July 21, 2021, by and between Arvinas, Inc. and Pfizer, Inc (Filed With SEC on July 22, 2021)
- Description of the Registrants Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on March 16, 2020)
- Investor Agreement between the Registrant and Bayer AG, dated July 16, 2019 (Filed With SEC on August 5, 2019)
- Option Agreement between Arvinas Operations, Inc. and Bayer CropScience LP, dated June 3, 2019 (Filed With SEC on August 5, 2019)
- Commitment Agreement between Arvinas Operations, Inc., Protag LLC, and Bayer CropScience LP, dated June 3, 2019 (Filed With SEC on August 5, 2019)
- Sponsored Research Agreement between The Silverstein Foundation for Parkinsons with GBA and Arvinas, Inc., dated March 7, 2018 (Filed With SEC on September 14, 2018)
- Form of Plan of Conversion (Filed With SEC on September 14, 2018)
- Sponsored Research Agreement between The Silverstein Foundation for Parkinsons with GBA and Arvinas, Inc., dated March 7, 2018 (Filed With SEC on August 30, 2018)
- Corporate Sponsored Research Agreement between Yale University and Arvinas, Inc., dated July 1, 2016, as amended by Amendment No. 1, dated April 1, 2018 (Filed With SEC on August 30, 2018)
- Second Amended and Restated Put Agreement among the Registrant, Connecticut Innovations, Incorporated and the other parties thereto, dated March 29, 2018 (Filed With SEC on August 30, 2018)
